Self-test diagnostic disasters threaten IVD (in vitro diagnostic) industry reputation
This article was originally published in Clinica
The UK market for self-tests has really started to take off - having risen by 11% in 2001. On the surface, this is obviously good news, but is it, in fact, so good for the national IVD industry? Amanda Maxwell asks
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”